Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice
- PMID: 33483762
- DOI: 10.1007/s00125-020-05378-z
Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice
Abstract
Aims/hypothesis: Stimulator of IFN genes (STING) is a central hub for cytosolic nucleic acid sensing and its activation results in upregulation of type I IFN production in innate immune cells. A type I IFN gene signature seen before the onset of type 1 diabetes has been suggested as a driver of disease initiation both in humans and in the NOD mouse model. A possible source of type I IFN is through activation of the STING pathway. Recent studies suggest that STING also has antiproliferative and proapoptotic functions in T cells that are independent of IFN. To investigate whether STING is involved in autoimmune diabetes, we examined the impact of genetic deletion of STING in NOD mice.
Methods: CRISPR/Cas9 gene editing was used to generate STING-deficient NOD mice. Quantitative real-time PCR was used to assess the level of type I IFN-regulated genes in islets from wild-type and STING-deficient NOD mice. The number of islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP)206-214-specific CD8+ T cells was determined by magnetic bead-based MHC tetramer enrichment and flow cytometry. The incidence of spontaneous diabetes and diabetes after adoptive transfer of T cells was determined.
Results: STING deficiency partially attenuated the type I IFN gene signature in islets but did not suppress insulitis. STING-deficient NOD mice accumulated an increased number of IGRP206-214-specific CD8+ T cells (2878 ± 642 cells in NOD.STING-/- mice and 728.8 ± 196 cells in wild-type NOD mice) in peripheral lymphoid tissue, associated with a higher incidence of spontaneous diabetes (95.5% in NOD.STING-/- mice and 86.2% in wild-type NOD mice). Splenocytes from STING-deficient mice rapidly induced diabetes after adoptive transfer into irradiated NOD recipients (median survival 75 days for NOD recipients of NOD.STING-/- mouse splenocytes and 121 days for NOD recipients of NOD mouse splenocytes).
Conclusions/interpretation: Data suggest that sensing of endogenous nucleic acids through the STING pathway may be partially responsible for the type I IFN gene signature but not autoimmunity in NOD mice. Our results show that the STING pathway may play an unexpected intrinsic role in suppressing the number of diabetogenic T cells.
Keywords: CD8+ T cells; NOD mice; STING; Type 1 diabetes; Type 1 interferon.
References
-
- Craig ME, Kim KW, Isaacs SR et al (2019) Early-life factors contributing to type 1 diabetes. Diabetologia 62(10):1823–1834. https://doi.org/10.1007/s00125-019-4942-x - DOI - PubMed
-
- Rewers M, Ludvigsson J (2016) Environmental risk factors for type 1 diabetes. Lancet 387(10035):2340–2348. https://doi.org/10.1016/S0140-6736(16)30507-4 - DOI - PubMed - PMC
-
- van der Werf N, Kroese FG, Rozing J, Hillebrands JL (2007) Viral infections as potential triggers of type 1 diabetes. Diabetes Metab Res Rev 23(3):169–183. https://doi.org/10.1002/dmrr.695 - DOI - PubMed
-
- Pane JA, Coulson BS (2015) Lessons from the mouse: potential contribution of bystander lymphocyte activation by viruses to human type 1 diabetes. Diabetologia 58(6):1149–1159. https://doi.org/10.1007/s00125-015-3562-3 - DOI - PubMed
-
- Ablasser A, Chen ZJ (2019) cGAS in action: Expanding roles in immunity and inflammation. Science 363(6431):eaat8657. https://doi.org/10.1126/science.aat8657 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
